纳米结构的库尔库明输送系统:改善在动脉样硬化中的生物可用性和斑块向效率
Yu Liu1, Tengfei Yu2, Chao Zhang3
1International Education Department, Henan Vocational College of Nursing, Anyang 455000, China.
Pharmaceutics
|November 27, 2025
概括
心血管疾病 (CVD) 是一个主要的全球杀手. 这篇评论探讨了黄素.
科学领域:
- 生物医学科学 生物医学科学
- 药理学 药理学是指药理学的学科.
- 自然产品 自然产品
背景情况:
- 心血管疾病 (CVD) 是全球死亡的主要原因,占非传染性疾病死亡人数的40%以上.
- 动脉样硬化 (AS),心血管疾病的主要贡献者,是一种由诸如高脂血症和高血压等因素驱动的慢性炎症状况.
- 天然生物活性化合物越来越多地被认为是治疗复杂疾病的治疗潜力.
研究的目的:
- 审查动脉样硬化 (AS) 的传统药理疗法.
- 阐明黄素 (Cur) 在AS中的治疗机制.
- 引入Cur的新型纳米配方,用于增强AS治疗.
主要方法:
- 对AS治疗药理学方法的文献综述.
- 对黄素的抗炎,降脂和内皮保护作用的科学数据的分析.
- 探索新兴的纳米配方,以提供黄素.
主要成果:
- 黄素表现出显著的抗炎,降脂,抗高血压和内皮保护性质,与AS相关.
- 黄素在AS中的治疗机制涉及调节关键的炎症途径.
- 新型纳米配方可以克服黄素的局限性,提高其生物可用性和有效性.
结论:
- 黄素作为治疗动脉样硬化和相关心血管疾病的治疗剂具有相当大的前景.
- 了解黄素的机制和利用纳米配方对于推进其在AS中的临床应用至关重要.
- 本综述为未来研究心血管疾病管理中的天然化合物提供了洞察力.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
176
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
176
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
185
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
185
Atherosclerosis III: Management
301
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
301
Bioavailability Enhancement: Drug Solubility Enhancement
204
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
204
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
161
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
161
Atherosclerosis I: Introduction
835
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
835


